Published • loading... • Updated
Astrazeneca Criticizes Planned Cuts in the Healthcare System
Summary by Berliner-sonntagsblatt.de
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
British pharmaceutical company AstraZeneca has warned of the potential consequences of cuts to the German healthcare system. Starting next year, the company will no longer be able to launch new research-based drugs on the German market, Pascal Soriot, CEO of the world's fifth-largest pharmaceutical company, told the Handelsblatt newspaper (Wednesday edition). "This is really not a threat. We will be attacked for this, but we have no other choice…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
